This is such a nothing story. A quote from the article itself: >To get around the sustainability issue overall, the report suggests that biotech companies foc

This is such a nothing story. A quote from the article itself: >To get around the sustainability issue overall, the report suggests that biotech companies focus on diseases or conditions that seem to be becoming more common and/or are already high-incidence. It also suggests that companies be innovative and constantly expanding their portfolio of treatments. This can “offset the declining revenue trajectory of prior assets." Lastly, it hints that, as such cures come to fruition, they could open up more investment opportunities in treatments for “disease of aging.” In other words, Sachs is saying that just because you cure a disease, that doesn't mean you can sit on your ass. You have to keep finding diseases to cure. O, the horror.